Changes of intrahepatic level of chemokine CCL25 and CX3CLl in rats with hepatic fibrosis

HUANG Jian-fang,JIANG Dao-wen,YANG Zhen,MA Jin,CHEN Qian

DOI: https://doi.org/10.3969/j.issn.1006-1533.2012.08.009

2012-01-01

Abstract:Objective :To investigate the intrabepatic level of chemokine CCL25 and CX3CL1 in normal and hepatic fibrosis rats.Method :Thirty rats were divided into three groups: normal liver group, 4 weeks liver fibrosis group and 6 weeks liver fibrosis model group(n = 10).The content of CCL25 and CX3CL1 in hepatic tissue was assayed by ELISA.Results :The levels of CCL25 in the normal liver group, hepatic fibrosis model group in 4 weeks and 6 weeks were(5.1 ± 1.4), ng/g, (11.5 ± 3.3) ng/g, (15.2 ± 3.5) ng/g, respectively, and the levels in the liver fibrosis groups were significantly higher than those in the normal liver group. The contents in CX3CL1 in the normal liver group, hepatic fibrosis model group in 4 weeks and 6 weeks were (3.1 ± 1.3) ng/g, (9.9 ± 2.5) ng/g, and (10.4 ± 2.7 ng/g), respectively and the contents in liver fibrosis groups were significantly higher than those in the normal liver group, whose difference was statistically significant. Conclusion: The chemokine CCL25 and CX3CLl in rat liver tissue were in the normal expression, but the number was at the low level of expression. While fibrosis of liver injury occurred, the liver content of CCL25 and CX3CL1 significantly increased, and with the disease development from hepatic fibrosis stage into cirrhosis one, liver CCL25 and CX3CLl showed different changes in the content, CCL25 expression was further increased, CX3CL1 expression was maintained at a high level.